Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.470
+0.030 (2.08%)
At close: Dec 20, 2024, 3:39 PM
1.479
+0.009 (0.64%)
After-hours: Dec 20, 2024, 7:52 PM EST
Can-Fite BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -7.37 | -7.63 | -10.17 | -12.62 | -14.44 | -12.63 | |
| Depreciation & Amortization | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Loss (Gain) From Sale of Investments | 0 | -0.01 | 0.23 | -0.16 | -0.01 | 0.21 | |
| Stock-Based Compensation | 0.36 | 0.26 | 0.26 | 0.47 | 0.36 | 0.39 | |
| Other Operating Activities | 0.16 | -0.13 | 0.17 | 0.01 | 0.03 | -0 | |
| Change in Accounts Payable | 0.08 | -0.47 | -0.06 | 0.39 | -1.6 | 1.09 | |
| Change in Unearned Revenue | -0.62 | -0.74 | -0.81 | 1.4 | -0.4 | 0.15 | |
| Change in Other Net Operating Assets | -0.05 | 0.27 | -0.43 | 0.64 | 3.99 | -0.3 | |
| Operating Cash Flow | -7.43 | -8.44 | -10.8 | -9.86 | -12.06 | -11.08 | |
| Capital Expenditures | -0 | -0 | -0.01 | -0.01 | -0.03 | -0 | |
| Investment in Securities | 6 | 0.5 | 9.51 | -14.5 | - | - | |
| Investing Cash Flow | 6 | 0.5 | 9.5 | -14.51 | -0.03 | -0 | |
| Issuance of Common Stock | 3 | 9.53 | - | 21.76 | 17.68 | 10.17 | |
| Other Financing Activities | -0.39 | -0.39 | - | -1.31 | - | - | |
| Financing Cash Flow | 2.62 | 9.14 | - | 20.46 | 17.68 | 10.17 | |
| Foreign Exchange Rate Adjustments | 0.08 | 0.1 | -0.11 | 0.03 | -0.02 | 0 | |
| Net Cash Flow | 1.26 | 1.3 | -1.41 | -3.88 | 5.57 | -0.92 | |
| Free Cash Flow | -7.44 | -8.44 | -10.81 | -9.87 | -12.09 | -11.09 | |
| Free Cash Flow Margin | -1114.69% | -1136.20% | -1334.57% | -1156.98% | -1584.40% | -545.62% | |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.03 | -0.13 | |
| Cash Interest Paid | - | - | - | 0.02 | 0.02 | 0.03 | |
| Levered Free Cash Flow | -4.55 | -5.12 | -6.51 | -5.98 | -7.41 | -7.63 | |
| Unlevered Free Cash Flow | -4.55 | -5.12 | -6.51 | -5.98 | -7.18 | -7.36 | |
| Change in Net Working Capital | 0.05 | 0.28 | 0.46 | -1.58 | -1.32 | 0.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.